Eudaimonia Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $565K | Sell |
726
-58
| -7% | -$45.1K | 0.13% | 147 |
|
|
2023
Q4 | $457K | Sell |
784
-1,154
| -60% | -$673K | 0.12% | 149 |
|
|
2023
Q3 | $1.04M | Sell |
1,938
-89
| -4% | -$47.8K | 0.25% | 90 |
|
|
2023
Q2 | $951K | Buy |
2,027
+37
| +2% | +$17.4K | 0.21% | 114 |
|
|
2023
Q1 | $684K | Sell |
1,990
-151
| -7% | -$51.9K | 0.16% | 135 |
|
|
2022
Q4 | $783K | Buy |
2,141
+57
| +3% | +$20.9K | 0.19% | 127 |
|
|
2022
Q3 | $674K | Sell |
2,084
-2,034
| -49% | -$658K | 0.18% | 131 |
|
|
2022
Q2 | $1.34M | Sell |
4,118
-281
| -6% | -$91.1K | 0.25% | 105 |
|
|
2022
Q1 | $1.26M | Buy |
+4,399
| New | +$1.26M | 0.21% | 126 |
|
|
2021
Q3 | $826K | Sell |
3,576
-2
| -0.1% | -$462 | 0.15% | 166 |
|
|
2021
Q2 | $821K | Sell |
3,578
-77
| -2% | -$17.7K | 0.15% | 162 |
|
|
2021
Q1 | $683K | Buy |
3,655
+7
| +0.2% | +$1.31K | 0.14% | 165 |
|
|
2020
Q4 | $616K | Sell |
3,648
-44
| -1% | -$7.43K | 0.14% | 166 |
|
|
2020
Q3 | $546K | Buy |
3,692
+772
| +26% | +$114K | 0.14% | 158 |
|
|
2020
Q2 | $479K | Sell |
2,920
-100
| -3% | -$16.4K | 0.18% | 131 |
|
|
2020
Q1 | $419K | Sell |
3,020
-443
| -13% | -$61.5K | 0.18% | 133 |
|
|
2019
Q4 | $455K | Buy |
+3,463
| New | +$455K | 0.18% | 134 |
|